From the 2022 Joint Annual Meeting (recorded 6/27/2022)
Presented by Susan McQuiston, SCYM(ASCP)CM

This presentation discusses the legal, regulatory, and ethical issues that arise when private companies provide DNA testing and interpretation to consumers without the guidance of trained medical professionals. Test quality in relation to results and polygenic risk scores with interpretation are also included.

LEARNING OBJECTIVES
At the conclusion of this presentation, participants will be able to:

• Discuss basic issues regarding accuracy of Direct to Consumer DNA testing.
• Discuss specific legal and regulatory issues regarding Direct to Consumer DNA Testing.
• Describe issues with interpretation of Direct to Consumer DNA Testing.

CE ACCREDITATION
ASCLS is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. One-half (0.5) P.A.C.E. ® contact hour in the area of Ethics/General will be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of Certification and all states, including Florida and California, as an approved provider of continuing education for recertification and licensure. ASCLS is an approved provider with CE Broker for Florida licensees.

LEVEL OF INSTRUCTION
This Intermediate-level program is appropriate